Sculpting the atherosclerotic plaque by neurotrophins
通过神经营养素塑造动脉粥样硬化斑块
基本信息
- 批准号:7406109
- 负责人:
- 金额:$ 42.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsApolipoprotein EApoptosisApoptoticArterial Fatty StreakBindingBiologicalBlood VesselsBrain-Derived Neurotrophic FactorCardiacCell DeathCellsCessation of lifeChemotaxisClassCleaved cellCodeDevelopmentEndopeptidasesEndothelial CellsExonsFamilyGoalsGrowth FactorHematopoieticHumanIn VitroInjuryLesionLigandsLocalizedMatrix MetalloproteinasesMediatingModelingMusNGFR ProteinNerve Growth Factor 1Nerve Growth Factor PathwayNeuronsNeurotrophin 3OutcomePeptide HydrolasesPlasminPlasminogenProtein OverexpressionReceptor Protein-Tyrosine KinasesRecruitment ActivityResistanceRoleSiteSmooth Muscle MyocytesSystemTechniquesTumor Necrosis Factor ReceptorVascular remodelingbrain-derived neurotrophic factor precursorfemoral arterygene replacementin vivomacrophagemembermonocytemutantneurotrophic factorreceptorresponse to injurytranscriptional coactivator p75
项目摘要
The development of atheroma is regulated in part by the localized expression of growth factors that promote the recruitment of hematopoietic cells as well as vascular smooth muscle cells into the neointima. We previously demonstrated that the neurotrophins and their receptors, the trk family of receptor tyrosine kinases and the p75 neurotrophin receptor (p75NTR), are highly expressed in atherosclerotic lesions. Three specific roles for the neurotrophins in regulating vessel development and in modulating the vascular response to injury have been identified:
(1) neurotrophin-mediates survival of Trk B-expressing cardiac endothelial cells (2) neurotrophin-induced recruitment of Trk A and Trk B-expressing vascular smooth muscle cells to the developing neointima following injury; (3) neurotrophin-induced activation of p75NTR-expressing smooth muscle cells in the neointima induces apoptotic cell death. The paradox of neurotrophin actions in the vasculature, mediating both pro-survival and pro-death outcomes, has recently been clarified by our identification that the pro-forms of the neurotrophins selectively bind to the proapoptotic p75NTR, whereas the mature ligand selectively activates the chemotactic and survival promoting Trk receptors. Our preliminary studies indicate that both the pro- and mature forms of the neurotrophins NGF and BDNF are expressed in human atherosclerotic lesions and atheroma from murine models, and that selective MMPs and
plasmin can cleave pro-forms to mature forms. The long term goals of this project are to understand how the differential expression of pro- and mature forms of neurotrophins regulate the dynamics of lesion formation and vascular remodeling. Studies in Specific Aim 1 will define the spatial and temporal expression of the pro- and mature forms of the neurotrophins in human lesions and in murine models of atheromata formation and correlate their expression with the co-ordinate expression of p75NTR and Trk receptors, as well as MMPs and components of the
plasminogen protease system. Studies in Specific Aim 2 will identify the biological actions of the pro-neurotrophins on vascular smooth muscle cells, monocytes/macrophages and endothelial cells using in vitro analysis of chemotaxis, survival and apoptosis and compare them to the actions of the mature neurotrophins. Finally, in Specific Aim 3, we will genetically dissect the actions of the pro-neurotrophins from mature neurotrophins in lesion formation in vivo by
replacing the native BDNF coding exon with a cleavage resistant mutant to generate only pro-BDNF. The effects of pro-BDNF overexpression in murine models of vascular injury will be assessed. The results of these studies may identify unique targets to regulate the microenvironment of the developing atheroma.
动脉粥样硬化的发展在一定程度上受生长因子的局部表达调控,生长因子促进造血细胞和血管平滑肌细胞向新生内膜募集。我们之前证明了神经营养因子及其受体,trk受体酪氨酸激酶家族和p75神经营养因子受体(p75NTR)在动脉粥样硬化病变中高度表达。神经营养因子在调节血管发育和调节血管损伤反应中的三种特定作用已被确定:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARBARA L HEMPSTEAD其他文献
BARBARA L HEMPSTEAD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARBARA L HEMPSTEAD', 18)}}的其他基金
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别:
Regulating BDNF Action in Postnatal Development.
调节 BDNF 在产后发育中的作用。
- 批准号:
8001977 - 财政年份:2009
- 资助金额:
$ 42.43万 - 项目类别:
Regulating BDNF Action in Postnatal Development.
调节 BDNF 在产后发育中的作用。
- 批准号:
7872723 - 财政年份:2009
- 资助金额:
$ 42.43万 - 项目类别:
Regulating BDNF Action in Postnatal Development.
调节 BDNF 在产后发育中的作用。
- 批准号:
8206532 - 财政年份:2009
- 资助金额:
$ 42.43万 - 项目类别:
Regulating BDNF Action in Postnatal Development.
调节 BDNF 在产后发育中的作用。
- 批准号:
8401143 - 财政年份:2009
- 资助金额:
$ 42.43万 - 项目类别:
Regulating BDNF Action in Postnatal Development.
调节 BDNF 在产后发育中的作用。
- 批准号:
7565724 - 财政年份:2009
- 资助金额:
$ 42.43万 - 项目类别:
Functional analysis of variant BDNF (Val66Met)
BDNF 变体 (Val66Met) 的功能分析
- 批准号:
8914167 - 财政年份:2005
- 资助金额:
$ 42.43万 - 项目类别:
Gordon Conference on Neurotrophic Factors (2003,2005)
戈登神经营养因子会议(2003,2005)
- 批准号:
6892371 - 财政年份:2003
- 资助金额:
$ 42.43万 - 项目类别:
Gordon Conference on Neurotrophic Factors (2003,2005)
戈登神经营养因子会议(2003,2005)
- 批准号:
6751906 - 财政年份:2003
- 资助金额:
$ 42.43万 - 项目类别:
Gordon Conference on Neurotrophic Factors (2003,2005)
戈登神经营养因子会议(2003,2005)
- 批准号:
6597988 - 财政年份:2003
- 资助金额:
$ 42.43万 - 项目类别:
相似海外基金
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology
人类载脂蛋白 E 同工型在西尼罗河病毒暴露对阿尔茨海默病相关行为改变、认知损伤、神经炎症和神经病理学的长期影响中的作用
- 批准号:
10658408 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别:
A Therapeutic Role for Apolipoprotein-E in the Germ Theory of Alzheimer's Dementia
载脂蛋白-E 在阿尔茨海默氏痴呆病菌理论中的治疗作用
- 批准号:
10601779 - 财政年份:2023
- 资助金额:
$ 42.43万 - 项目类别:
Investigating how apolipoprotein E genotypes modify fatty acid metabolism
研究载脂蛋白 E 基因型如何改变脂肪酸代谢
- 批准号:
RGPIN-2018-06116 - 财政年份:2022
- 资助金额:
$ 42.43万 - 项目类别:
Discovery Grants Program - Individual
Targeting apolipoprotein E for Alzheimer's disease therapy.
靶向载脂蛋白 E 治疗阿尔茨海默病。
- 批准号:
22K06460 - 财政年份:2022
- 资助金额:
$ 42.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
- 批准号:
10674878 - 财政年份:2022
- 资助金额:
$ 42.43万 - 项目类别:
Apolipoprotein E and immunometabolism in Alzheimer's disease
载脂蛋白 E 和阿尔茨海默病的免疫代谢
- 批准号:
10388528 - 财政年份:2022
- 资助金额:
$ 42.43万 - 项目类别:
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
- 批准号:
10515592 - 财政年份:2022
- 资助金额:
$ 42.43万 - 项目类别:
Apolipoprotein E and immunometabolism in Alzheimer's disease
载脂蛋白 E 与阿尔茨海默病的免疫代谢
- 批准号:
10644996 - 财政年份:2022
- 资助金额:
$ 42.43万 - 项目类别:
Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis
载脂蛋白E糖基化及其在阿尔茨海默病发病机制中的作用
- 批准号:
10601040 - 财政年份:2021
- 资助金额:
$ 42.43万 - 项目类别:
Impact of cysteine modifications of apolipoprotein E on the remnant lipoprotein metabolism
载脂蛋白E半胱氨酸修饰对残余脂蛋白代谢的影响
- 批准号:
21K07310 - 财政年份:2021
- 资助金额:
$ 42.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




